Loading the company…
Loading the company…
㈜코넥스트(CONNEXT Co.,Ltd.)
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daegu, founded in 2017. Industry: Bio & Pharma. Group consolidated revenue for 2025 was ₩70.0m — this includes subsidiaries and is not the revenue of this entity alone. It has 7 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2023-03-08 · latest registration 2026-02-11 · newest first
본 발명은 효소로서 콜라게네이즈(Collagenase); 조효소로서 칼슘, 히스티딘(Histidine); 및 글리신(Glycine)을 포함하는 조성물 및 콜라게네이즈(Collagenase)에 히스티딘 및 글리신을 추가하여 조성물을 제조하는 것을 포함하는 효소의 안정화 방법을 제공한다. 이러한 본 발명의 효소 조성물 및 효소의 안정화 방법에 따르면, 효소의 응집을 최소화하거나 억제할 수 있고, 장기간 보관시에도 동결건조된 효소의 농도가 떨어지지 않으면서, 액상 복원 시간과 함습도가 우수하며, 효소의 활성도 우수한 제형을 제공할 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 0.1 | 0.1 |
| Cost of sales | 0.1 | 0.1 |
| Gross profit (loss) | 0.0 | (0.0) |
| Selling, general and administrative expenses | 4.2 | 4.0 |
| Operating income (loss) | (4.1) | (3.6) |
| Non-operating income | 0.0 | 0.0 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Non-operating expenses | 1.1 | 1.0 |
| Other losses | 0.1 | 0.0 |
| Finance costs | 1.0 | 1.0 |
| Profit (loss) before tax | (5.2) | (4.6) |
| Net income (loss) | (5.2) | (4.6) |
Revenue ₩0.1bn, down 8.4% YoY.
Operating margin -5181.7% (prior -5390.1%).
Net income ₩-4.6bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.